Clinical Trial Update: Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ticagrelor and clopidogrel in patients with type 2 diabetes and coronary artery disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: Juan J Badimon | Conditions: Type-2 Diabetes Mellitus, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-09-01